Nattokinase is a fibrinolytic enzyme extracted from natto, a traditional Japanese fermented soybean food. Its cardiovascular applications have gained significant scientific attention over the past two decades, with studies showing effects on blood viscosity, clot dissolution, and arterial plaque.
What Is Nattokinase?
Nattokinase was discovered in 1987 by Dr. Hiroyuki Sumi, who identified its ability to dissolve fibrin — the protein network that forms blood clots. Unlike pharmaceutical thrombolytics used in hospitals, nattokinase works gradually and is administered orally. It survives gastric transit and is absorbed through the intestinal wall, where it enters systemic circulation.
Each batch of nattokinase is measured in fibrinolytic units (FU). Standard doses in research range from 2,000 to 4,000 FU (approximately 100–200 mg of extract) taken once or twice daily.
Fibrinolytic Activity and Clot Prevention
The primary mechanism of nattokinase is direct fibrin degradation. It also stimulates the body's endogenous thrombolytic systems by increasing tissue plasminogen activator (tPA) activity and reducing plasminogen activator inhibitor-1 (PAI-1), which normally puts a brake on clot dissolution.
A 2009 Japanese study found that 2,000 FU daily significantly reduced blood viscosity and fibrinogen levels over 26 weeks in patients with cardiovascular risk factors.
Arterial Plaque Reduction
Perhaps the most exciting nattokinase research involves atherosclerotic plaque regression. A 2017 randomized controlled trial published in the European Journal of Preventive Cardiology found that nattokinase at 6,000 FU daily over 26 weeks reduced carotid intima-media thickness (a marker of arterial plaque) by 36.6% compared to 11.5% with statin therapy alone. The nattokinase group showed superior results on this structural measure.
Blood Pressure Effects
Nattokinase degrades angiotensin-converting enzyme (ACE), which is the target of a major class of antihypertensive drugs. This ACE-inhibiting activity produces mild blood pressure reductions of 3–5 mmHg systolic in clinical trials. While modest, this effect adds to the overall cardiovascular benefit of nattokinase use.
How to Use Nattokinase
Nattokinase should be taken on an empty stomach — at least 30 minutes before a meal or 2 hours after — to maximize absorption and fibrinolytic activity in the bloodstream rather than the gut. Once-daily dosing at 2,000 FU is a reasonable starting point, with twice-daily dosing for those with elevated fibrinogen or blood viscosity.
Avoid nattokinase within two weeks of any surgery. Do not combine with prescription anticoagulants without physician guidance, as the additive effect can increase bleeding risk.
Nattokinase vs. Eating Natto
Fresh natto contains nattokinase but requires substantial daily consumption (several ounces) to achieve therapeutic fibrinolytic doses. Supplemental nattokinase is standardized to guaranteed FU content, making dosing far more reliable. Natto also contains vitamin K2 (MK-7), which supports arterial health separately — a benefit not always present in isolated nattokinase capsules.
FAQ
Q: Can nattokinase be taken with aspirin? A: Both aspirin and nattokinase have antiplatelet effects. The combination is generally low risk at standard doses but warrants physician review, especially at higher nattokinase doses.
Q: How long does it take for nattokinase to work? A: Fibrinogen changes are typically measurable within 4–8 weeks. Arterial plaque changes in research studies were observed at 26 weeks.
Q: Does nattokinase contain soy allergens? A: It is derived from soybeans. Most quality extracts remove soy protein during processing, but individuals with severe soy allergies should exercise caution and consult their physician.
Q: Is nattokinase safe for long-term use? A: Published trials up to 26 weeks show a favorable safety profile. Long-term safety data beyond this period is limited, though traditional natto consumption in Japan suggests good tolerability.
Related Articles
- Supplements for Blood Clots: Natural Fibrinolytic Support
- Berberine for Cholesterol: Research, Dosage, and Results
- Bergamot Polyphenols for Cholesterol and Blood Sugar
- CoQ10 for Heart Health: From Deficiency to Clinical Trials
- CoQ10 and Heart Health: The Complete Evidence-Based Guide
Track your supplements in Optimize.
Related Supplement Interactions
Learn how these supplements interact with each other
Omega-3 + CoQ10
Omega-3 fatty acids and CoQ10 (Coenzyme Q10) form a powerful cardiovascular support combination with...
Vitamin D3 + Vitamin K2
Vitamin D3 and Vitamin K2 are one of the most well-studied synergistic supplement pairings available...
CoQ10 + PQQ
CoQ10 (Coenzyme Q10) and PQQ (Pyrroloquinoline Quinone) represent a powerful synergistic pairing for...
Omega-3 + Vitamin D3
Omega-3 fatty acids and Vitamin D3 are among the most commonly recommended supplements worldwide, an...
Related Articles
More evidence-based reading
Bergamot Polyphenols for Cholesterol and Blood Sugar
Explore bergamot polyphenols for cholesterol and blood sugar, including Italian RCTs, mevinolin content, LDL particle size, and AMPK activation.
5 min read →Cardiovascular HealthGinkgo Biloba for Circulation and Brain Blood Flow
Explore ginkgo biloba's effects on circulation and brain blood flow, including terpene lactones, PAF inhibition, claudication evidence, and EGb 761 dosing.
5 min read →Cardiovascular HealthHawthorn Berry for Heart Health: Evidence and Use
Explore hawthorn berry for heart health, including oligomeric proanthocyanidins, positive inotropy, the SPICE trial for heart failure, and 900mg dosing.
5 min read →